Logo-apb
Adv Pharm Bull. 2023;13(4): 678-687. doi: 10.34172/apb.2023.069

Review Article

Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications

Minu Treeza M 1 ORCID, Sanu Augustine 1 ORCID, Aparna Ann Mathew 1 ORCID, S.K. Kanthlal 1 * ORCID, Rajitha Panonummal 1 * ORCID

Cited by CrossRef: 0


1- Zhang J, Hom K, Zhang C, Nasr M, Gerzanich V, Zhang Y, Tang Q, Xue F, Simard J, Zhao R. SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects. Pathogens. 2024;13(1):75 [Crossref]